Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Bolt Biotherapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BOLT.
You can purchase shares of Bolt Biotherapeutics (NASDAQ:BOLT) through any online brokerage.
Other companies in Bolt Biotherapeutics’s space includes: Cellectar Biosciences (NASDAQ:CLRB), Curis (NASDAQ:CRIS), Imunon (NASDAQ:IMNN), Can Fite Biofarma (AMEX:CANF) and BioRestorative Therapies (NASDAQ:BRTX).
Bolt Biotherapeutics has a consensus price target of $2.31.
The stock price for Bolt Biotherapeutics (NASDAQ: BOLT) is $0.34 last updated April 21, 2025 at 12:23 PM EDT.
A quarterly cash dividend of 0.09 per share of Class A Common Stock. The quarterly cash dividend was payable on October 2, 2014 to stockholders of record on September 1, 2014.
Bolt Biotherapeutics’s Q1 earnings are confirmed for Tuesday, May 13, 2025.
There is no upcoming split for Bolt Biotherapeutics.
Bolt Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.